Insider · CIK 0001620368

Sandor Victor

Reports to the SEC for 6 companies · VANCOUVER

sec.gov

Transactions

Companies

Filings

CIK

0001620368

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director	AAward	+152K sh	—	—	152,207
2026-06-24	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,068 sh	—	—	6,068
2026-06-09	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2026-06-03	ADCTADC Therapeutics SAF Tax Payment	Director	FTax Payment	−12.6K sh	$3.08	−$38.8K	140,686
2026-06-01	ADCTADC Therapeutics SAA Award	Director	AAward	+45K sh	—	—	153,286
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,844 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.4K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.6K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,120 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,631 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2025-11-05	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+121K sh	—	—	121,285
2025-06-25	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-06-13	ADCTADC Therapeutics SAF Tax Payment	Director	FTax Payment	−12.6K sh	$3.58	−$45.1K	108,286
2025-06-12	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2025-06-03	ADCTADC Therapeutics SAA Award	Director	AAward	+40K sh	—	—	120,886
2025-05-22	MRUSMerus N.V. · Share Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,193
2024-06-18	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-06-17	ADCTADC Therapeutics SAS Sale	Director	SSale	−6,995 sh	$2.89	−$20.2K	80,886
2024-06-14	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2024-06-13	ADCTADC Therapeutics SAA Award	Director	AAward	+40K sh	—	—	87,881
2024-05-07	MRUSMerus N.V. · Share Option (right to buy)A Award	Director	AAward	+8,844 sh	—	—	8,844
2023-06-16	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2023-06-15	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-06-08	MRUSMerus N.V. · Share option (right to buy)A Award	Director	AAward	+14.4K sh	—	—	14,414
2022-11-03	KYMRKymera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2022-06-17	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+34.3K sh	—	—	34,300
2022-05-31	MRUSMerus N.V. · Share option (right to buy)A Award	Director	AAward	+16.6K sh	—	—	16,604
2022-01-03	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,206
2021-10-13	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,022 sh	—	—	8,022
2021-06-18	PRLDPrelude Therapeutics Inc · Director Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,344
2021-05-28	MRUSMerus N.V. · Share option (right to buy)A Award	Director	AAward	+6,120 sh	—	—	6,120
2020-09-24	PRLDPrelude Therapeutics Inc · Director Stock Option (right to buy)A Award	Director	AAward	+3,458 sh	—	—	3,458
2020-06-30	MRUSMerus N.V. · Share Option (right to buy)A Award	Director	AAward	+8,631 sh	—	—	8,631
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−210K sh	$48.00	−$10.1M	114,821
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−115K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−87.5K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−188K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−271K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−290K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−290K sh	—	—	0
2019-06-04	ARRAY BIOPHARMA INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+100K sh	$7.30	+$730K	309,543
2019-06-04	ARRAY BIOPHARMA INCS Sale	Chief Medical Officer	SSale	−100K sh	$28.51	−$2.85M	209,543
2019-06-04	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−100K sh	—	—	87,500
2019-06-03	ARRAY BIOPHARMA INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+36.1K sh	$3.65	+$132K	245,677
2019-06-03	ARRAY BIOPHARMA INCS Sale	Chief Medical Officer	SSale	−36.1K sh	$27.58	−$997K	209,543
2019-06-03	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−36.1K sh	—	—	0
2019-05-30	ARRAY BIOPHARMA INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15.7K sh	$3.65	+$57.4K	225,271
2019-05-30	ARRAY BIOPHARMA INCS Sale	Chief Medical Officer	SSale	−15.7K sh	$27.50	−$433K	209,543

Recent filings

Accepted (ET)
Jul 64
Sandor Victor0001628280-26-047396
SEC(opens sec.gov)
Jun 254
Sandor Victor0001193125-26-283135
SEC(opens sec.gov)
Jun 104
Sandor Victor0001620368-26-000003
SEC(opens sec.gov)
Jun 34
Sandor Victor0001628280-26-040491
SEC(opens sec.gov)
Dec 124
Sandor Victor0001193125-25-317939
SEC(opens sec.gov)
Nov 74
Sandor Victor0001620368-25-000005
SEC(opens sec.gov)
Jun 264
Sandor Victor0000950170-25-090580
SEC(opens sec.gov)
Jun 174
Sandor Victor0001628280-25-031894
SEC(opens sec.gov)
Jun 134
Sandor Victor0001562180-25-004798
SEC(opens sec.gov)
Jun 54
Sandor Victor0001628280-25-029739
SEC(opens sec.gov)
May 274
Sandor Victor0000950170-25-077384
SEC(opens sec.gov)
Jun 204
Sandor Victor0000950170-24-075707
SEC(opens sec.gov)
Jun 184
Sandor Victor0001628280-24-028988
SEC(opens sec.gov)

Companies

Address

C/O ABCELLERA BIOLOGICS INC 150 W 4TH AVENUE

VANCOUVER